Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers October 22, 2017

Poll Results
How likely would you be to recommend Qtern® in a patient already receiving dapagliflozin and saxagliptin with good blood glucose control?
  Very likely 8.0%
  Somewhat likely 8.0%
  Neutral / no opinion yet 24.0%
  Somewhat unlikely 12.0%
  Very unlikely 48.0%

  Total # Taken: 25

Previous Polls
How often have you seen Riluzole (Rilutek) prescribed for ALS ?
How often have you encountered patients who have developed tardive dyskinesia from antipsychotic drug use?
How often have you encountered patients who have developed tardive dyskinesia from antipsychotic drug use?
How often do you see denosumab prescribed to treat osteoporosis?
How likely would you be to recommend Qtern® in a patient already receiving dapagliflozin and saxagliptin with good blood glucose control?
How likely would you be to recommend Basaglar® as an alternative to Lantus®?
How likely would you be to recommend safinamide for a patient with Parkinson’s disease on levodopa/carbidopa with significant “off” periods?
Do you agree that a target blood pressure of 140/90 or less is appropriate for most low-risk patients less than 60 years of age?
How often have you encountered the new heart failure drug, ivabradine (Corlanor), as either non-formulary, or prior authorization only status?
How often have you counseled about potential long-term side effects and/or Black Box warnings with topical tacrolimus or pimecrolimus?


Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415